Otto Juhani Kauko

Research activity per year

If you made any changes in Pure these will be visible here soon.

PP2A-based triple-strike therapy overcomes mitochondrial apoptosis resistance in brain cancer cells
Denisova, O. V., Merisaari, J., Huhtaniemi, R., Qiao, X., Yetukuri, L., Jumppanen, M., Kaur, A., Paakkonen, M., von Schantz-Fant, C., Ohlmeyer, M., Wennerberg, K., Kauko, O., Koch, R., Aittokallio, T., Taipale, M. & Westermarck, J., Sep 2023, In: Molecular oncology. 17, 9, p. 1803-1820 18 p.
Research output: Contribution to journal › Article › Scientific › peer-review

Open Access
File
PP2A methylesterase PME-1 suppresses anoikis and is associated with therapy relapse of PTEN-deficient prostate cancers
Aakula, A., Isomursu, A., Rupp, C., Erickson, A., Gupta, N., Kauko, O., Shah, P., Padzik, A., Pokharel, Y. R., Kaur, A., Li, S-P., Trotman, L., Taimen, P., Rannikko, A., Lammerding, J., Paatero, I., Mirtti, T., Ivaska, J. & Westermarck, J., Jun 2023, In: Molecular oncology. 17, 6, p. 1007-1023 17 p.
Research output: Contribution to journal › Article › Scientific › peer-review

Open Access
A competitive precision CRISPR method to identify the fitness effects of transcription factor binding sites
Pihlajamaa, P., Kauko, O., Sahu, B., Kivioja, T. & Taipale, J., 26 Sep 2022, In: Nature Biotechnology. 41, p. 197–203 26 p.
Research output: Contribution to journal › Article › Scientific › peer-review

Open Access
File

Personal profile